Reply to: Association between nilotinib-induced hyperbilirubinemia and UGT1A1 polymorphisms in a chronic myeloid leukemia patient

被引：0
作者：
Cattaneo, Daniele [1 ,2 ]
Iurlo, Alessandra [1 ]
机构：
[1] Fdn IRCCS CaGranda Osped Maggiore Policlin, Hematol Div, Milan, Italy
[2] Univ Milan, Dept Oncol & Hemato Oncol, Via Festa Perdono 7, I-20122 Milan, Italy
来源：
ANTI-CANCER DRUGS | 2025年 / 36卷 / 06期
关键词：
D O I：
10.1097/CAD.0000000000001709
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 5 条
  • [1] Alarcn-Payer C., 2025, Anticancer Drugs
  • [2] Gilbert syndrome redefined: A complex genetic haplotype influences the regulation of glucuronidation
    Ehmer, Ursula
    Kalthoff, Sandra
    Fakundiny, Bastian
    Pabst, Brigitte
    Freiberg, Nicole
    Naumann, Ronald
    Manns, Michael P.
    Strassburg, Christian P.
    [J]. HEPATOLOGY, 2012, 55 (06) : 1912 - 1921
  • [3] European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
    Hochhaus, A.
    Baccarani, M.
    Silver, R. T.
    Schiffer, C.
    Apperley, J. F.
    Cervantes, F.
    Clark, R. E.
    Cortes, J. E.
    Deininger, M. W.
    Guilhot, F.
    Hjorth-Hansen, H.
    Hughes, T. P.
    Janssen, J. J. W. M.
    Kantarjian, H. M.
    Kim, D. W.
    Larson, R. A.
    Lipton, J. H.
    Mahon, F. X.
    Mayer, J.
    Nicolini, F.
    Niederwieser, D.
    Pane, F.
    Radich, J. P.
    Rea, D.
    Richter, J.
    Rosti, G.
    Rousselot, P.
    Saglio, G.
    Saussele, S.
    Soverini, S.
    Steegmann, J. L.
    Turkina, A.
    Zaritskey, A.
    Hehlmann, R.
    [J]. LEUKEMIA, 2020, 34 (04) : 966 - 984
  • [4] UGT1A1 genotype does not affect tyrosine kinase inhibitors efficacy and safety in chronic myeloid leukemia
    Iurlo, Alessandra
    Bucelli, Cristina
    Cattaneo, Daniele
    Levati, Giorgia Virginia
    Viani, Benedetta
    Tavazzi, Dario
    Consonni, Dario
    Baldini, Luca
    Cappellini, Maria Domenica
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (11) : E283 - E285
  • [5] European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia
    Steegmann, J. L.
    Baccarani, M.
    Breccia, M.
    Casado, L. F.
    Garcia-Gutierrez, V.
    Hochhaus, A.
    Kim, D-W
    Kim, T. D.
    Khoury, H. J.
    Le Coutre, P.
    Mayer, J.
    Milojkovic, D.
    Porkka, K.
    Rea, D.
    Rosti, G.
    Saussele, S.
    Hehlmann, R.
    Clark, R. E.
    [J]. LEUKEMIA, 2016, 30 (08) : 1648 - 1671
1